COMMUNIQUÉS West-GlobeNewswire

Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
14/06/2019
RANCHO CUCAMONGA, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, will be presenting at the Raymond James Life Sciences and MedTech [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
14/06/2019
Company announcement – No. 22 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, June 14, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 [...]
TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following Bunionectomy
14/06/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 14, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop Early
14/06/2019
LONDON, June 14, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) today announces that the independent Data Monitoring Committee (“IDMC”) of the Phase III pivotal study of s [...]
Philips Research wins Dutch Hendrik Lorentz Award for its pioneering use of data science and artificial intelligence in healthcare
14/06/2019
June 14, 2019 Philips’ AI-powered adaptive intelligence solutions help people to live healthy lifestyles, improve patient outcomes, reduce healthcare costs, and enhance the patient and staff experience Amsterdam, the [...]
ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
14/06/2019
Amsterdam, The Netherlands – 14 June 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) is pleased to announce that it has agreed an extension of the maturity dates for EUR 4,750,000 in unsecured convertible loan notes ( [...]
GBT Announces Updated 24-Week Efficacy Data from All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor
14/06/2019
Data Supporting the Potential of Voxelotor as a Disease-Modifying Treatment for Sickle Cell Disease (SCD) Published in The New England Journal of Medicine and to be Presented During Presidential Symposium at the 24 th [...]
Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)
14/06/2019
Results from two Phase II trials, ENESTfreedom and ENESTop, support and extend previous findings of long-term durability of molecular response after stopping Tasigna, reducing time on drug for many CML patients 1,2 New [...]
BeiGene Announces Clinical Results from Three Posters on Zanubrutinib Presented at the 24th Congress of European Hematology Association (EHA)
14/06/2019
First Preliminary Data from Exploratory MYD88 WT Patient Cohort in Phase 3 Trial in Waldenström’s Macroglobulinemia (WM) ; Updated Phase 1/2 WM Data; and Pooled Safety Data Analysis on Zanubrutinib in B-Cell [...]
BeiGene Announces Updated Results from a Pivotal Phase 2 Study of Tislelizumab in Chinese Patients with Relapsed or Refractory Classical Hodgkin Lymphoma at the 24th Congress of the European Hematology Association (EHA)
14/06/2019
Company to Host Investor Conference Call and Webcast of Mid-2019 Clinical Data Updates on Thursday, June 20 at 8:00 a.m. EDT CAMBRIDGE, Mass. and BEIJING, China, June 14, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: [...]
Olainfarm Group sales in May increase by 20%
14/06/2019
Consolidated sales – May and 5 months Preliminary consolidated results of JSC Olainfarm for May 2019, show that the Group has made sales worth 10.4 million euros, which represents an increase by 20% compared to May 2018 [...]
Align Technology and Straumann Group Terminate Discussions Concerning a Possible Development and Distribution Agreement
14/06/2019
Straumann To Pay Align an Additional $16 Million to Complete Patent Settlement SAN JOSE, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) and Straumann Group today announced that they have [...]
Ascent Industries Provides Bi-Weekly Default Status Report
14/06/2019
VANCOUVER, British Columbia, June 13, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. ( CSE: ASNT ) (“ Ascent ” or the “ Company ”) is providing this bi-weekly default status report in accordance with National Policy [...]
Unum Therapeutics Strengthens and Expands Leadership Team
14/06/2019
– Matthew Osborne Appointed as Chief Financial Officer – – Jessica Sachs Promoted to Chief Medical Officer – – Mert Aktar Appointed as Head of Business and Corporate Development – CAMBRIDGE, Mass., June 13, 2019 (GLOBE [...]
Oncology Venture provides financial details regarding its recent acquisition of additional ownership in dovitinib
13/06/2019
Press release Hoersholm, Denmark, June 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today informs that the previously announced acquisition of an additional 8% ownership in the dovitinib project [...]
Profound Medical Annual and Special Meeting of Shareholders Voting Results
13/06/2019
TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Progenics to Mail Letter to Shareholders
13/06/2019
Asks Shareholders to Vote “FOR” All the Company’s Qualified Directors on the WHITE Proxy Card NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“Progenics” or the “Company”), an [...]
VBI Vaccines Announces Results of Annual General Meeting
13/06/2019
CAMBRIDGE, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI" or the "Company"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno- [...]
GENFIT: Outcome of the Ordinary Shareholder’s Meeting of June 13, 2019
13/06/2019
GENFIT: Outcome of the Ordinary Shareholder’s Meeting of June 13, 2019 Lille (France), Cambridge (Massachusetts, United States), June 13, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical [...]

Pages